FixUp Health, Inc., an AI-based remote therapeutic monitoring (RTM) startup, announced on the 17th that it has secured seed funding from Korea Investment Accelerator and Synergy IB Investment. This round follows a previous pre-seed investment and aims to expand its market share in the US rehabilitation healthcare market.
FixUpHealth, headquartered in the United States, was founded by a clinical director with a Harvard School of Public Health degree and clinical experience in rehabilitation. The US rehabilitation healthcare market faces structural challenges, including low patient compliance, high dropout rates, and excessive administrative workload. FixUpHealth leverages AI analytics and automation to improve patient care continuity and quality of care. It also analyzes health data and exercise performance information in real time to identify risk factors early and support clinical decision-making.
FixUp Health has proven its technology and service reliability, being used in hospitals and clinics across the United States, including those affiliated with Harvard Medical School. The number of users is rapidly increasing across a diverse client base, from independent practices to university hospital outpatient centers. This investment will accelerate service expansion, focusing on major US cities.
Nam Woo-hyun, team leader at Korea Investment Accelerator, said, “RTM is emerging as a new treatment paradigm as a means to achieve treatment continuity and effective early intervention,” and added, “FixUp Health is a team with strong execution capabilities led by Korean experts, and we expect growth in the U.S. rehabilitation medical market.”
“The US rehabilitation medical market has significant room for innovation due to administrative burdens and inefficiencies,” said Im Sang-won, CEO of FixUp Health. “Based on this investment, we will advance our AI-based RTM technology and contribute to building a rehabilitation medical infrastructure across the US.”
- See more related articles
You must be logged in to post a comment.